CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
15 oct. 2021 04h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
CLS Exhibits High Precision, Image-Guided Focal Laser Ablation System at the 73rd Congress of the German Society for Urology Conference
14 sept. 2021 03h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
STUTTGART, Germany, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
19 juil. 2021 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
19 juil. 2021 02h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
12 juil. 2021 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has...
CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
12 juil. 2021 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has received...
CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
07 juil. 2021 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 07, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its...
CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
07 juil. 2021 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its...
CLS Americas Continues Clinical Collaborations from New West Coast Office at Spectrum Office Plaza in Irvine, CA
14 janv. 2021 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced it has relocated its U.S. headquarters to a new office in the Irvine Spectrum Office...
CLS Strengthens its Organization with New Employees in Key Positions for Continued Global Establishment
13 janv. 2021 03h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), a developer of advanced innovative products for high-precision, image-guided laser ablation, today...